The molecular biology of NF2/Merlin on tumorigenesis and development

Rexhina Vlashi1, Fuju Sun1, Chenggong Zheng1

  • 1College of Life Science and Medicine, Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, Zhejiang Sci-Tech University, Hangzhou, China.

Insights

The neurofibromatosis type 2 (NF2) gene

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • The neurofibromatosis type 2 (NF2) gene encodes the tumor suppressor protein Merlin.
  • NF2/Merlin is critical for understanding tumorigenesis and cellular processes.
  • NF2 mutations are implicated in schwannomas, meningiomas, and ependymomas.

Purpose of the Study:

  • To comprehensively review the multifaceted role of NF2/Merlin.
  • To detail its structural characteristics, functional diversity, and pathway involvement.
  • To explore its role in embryogenesis and potential therapeutic strategies.

Main Methods:

  • Literature review of NF2/Merlin's function and associated pathways.
  • Analysis of NF2 mutations in specific tumor types.
  • Discussion of therapeutic strategies targeting NF2-related aberrations.

Main Results:

  • NF2/Merlin participates in key signaling pathways (Wnt/β-catenin, Hippo, mTOR, etc.).
  • NF2 deficiency causes severe developmental defects and embryonic lethality.
  • Inhibitors of mTOR, HDAC, and VEGF show therapeutic potential.

Conclusions:

  • NF2/Merlin plays a crucial role in cell growth, differentiation, and development.
  • Further research is needed to clarify tumor formation mechanisms.
  • Targeted therapies offer promise for improving patient outcomes in NF2-related conditions.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.2K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K